Novo Nordisk A/SNVONYSE
Loading
Net Margin Over TimeStable
Percentile Rank50
3Y CAGR+1.8%
5Y CAGR-0.0%
Studio
Year-over-Year Change

Net income as a percentage of revenue

3Y CAGR
+1.8%/yr
vs -2.4%/yr prior
5Y CAGR
-0.0%/yr
Consistent
Acceleration
+4.2pp
Accelerating
Percentile
P50
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
2 yr
Consecutive declineStable
PeriodValueYoY Change
202533.14%-4.7%
202434.78%-3.5%
202336.03%+14.8%
202231.38%-7.5%
202133.92%+2.2%
202033.19%+4.0%
201931.92%-7.6%
201834.54%+1.2%
201734.14%+0.6%
201633.93%-